Your denials can be cut, thanks to this easy tip. Single Code Helps Simplify Things Physicians rely on repetitive stimulation studies to identify and differentiate disorders of the NMJ, such as myasthenia gravis (358.00, Myasthenia gravis without [acute] exacerbation; or 358.01, Myasthenia gravis with acute exacerbation). When your physician completes NMJ testing, you report 95937 (Neuromuscular junction testing [repetitive stimulation, paired stimuli], each nerve, any 1 method). That's simple enough, but the term "each nerve" in the descriptor trips up some coders when they're faced with multiple stimulations. Tip: Example: The physician repeatedly tests three separate and distinct nerves -- the ulnar motor nerve to the abductor digiti minimi muscle, the median motor nerve to the abductor pollicis brevis muscle, and the spinal accessory nerve to the upper trapezius muscle. When filing the claim, you'll report a single line item of 95937 with "3" in the units field. Don't Jump to Modifiers 50 or 51 Seeing documentation of what seems to be a bilateral nerve test (such as a procedure on the right and left upper extremities) doesn't mean you automatically append modifier 50 (Bilateral procedure). Explanation: Avoid 51: Look for Other Procedures The "Frequency of Utilization" table in CPT's Appendix J includes guidelines for reporting 95937. NMJ testing for a final diagnosis of neuromuscular junction dysfunction has a maximum recommended study number of three. "Code 95937 may be performed in conjunction with sensory and motor nerve conduction studies (NCS) of the same nerves, and are reimbursed separately," says Marianne Wink, RHIT, CPC, ACS-EM, with the University of Rochester Medical Center. Your neurosurgeon's documentation for each nerve tested should note characteristics of the test, including the rate of repetition of stimulations, and significant incremental or decremental response.